# Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis

> **NCT00760149** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 150 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Rifampicin in higher doses

## Key facts

- **NCT ID:** NCT00760149
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-09-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760149, "Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00760149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*